Studies have identified that elevated levels of SPP1 are associated with increased neuroinflammation and neurodegeneration; thus, SPP1 is upregulated in several neuro-disorders, including multiple sclerosis, AD, and age-related macular degeneration [75,76]. Here, SPP1 is linked to Alzheimer disease.